Presentation THT 2026 Comparing the Strategy of LVAD versus Heart Transplantation Listing by Age in National US Data: Informing Patient Centered Decision Making Presenter: Thomas Cascino March 02, 2026
Presentation THT 2026 Antagonist: Deep Phenotyping and Phenomapping Has Been and Will Continue to Be A Mirage in Understanding the Mechanisms and Tailoring Treatment for HFpEF. Presenter: Milton Packer March 02, 2026
Presentation THT 2026 Implantable Pressure-Base Remote Monitoring Devices: What are the Differences? Presenter: Liviu Klein March 02, 2026
Presentation THT 2026 Clinical Viewpoint: Fallout from the IABP Shock II and Alt-Shock Studies Presenter: Joyce Wanglee Wald March 02, 2026
Presentation THT 2026 Protagonist: HFpEF is Highly Heterogeneous, Requiring a Multimodal Precision Medicine Approach for True Progress. Presenter: Sanjiv J. Shah March 02, 2026
Presentation THT 2026 Remote Monitoring to Optimize GDMT Beyond Diuretics Presenter: Lynne Warner Stevenson March 02, 2026
Presentation THT 2026 Perioperative Management and Outcomes of Heparin-Induced Thrombocytopenia in Patients Undergoing HeartMate 3 Left Ventricular Assist Device Implantation: A Case Series Presenter: Vaidehi Mendpara March 02, 2026
Presentation THT 2026 Introduction: The Hemodynamic Basis of the Use of IABP in AMI- and HF-Shock Presenter: Francesco Castagna March 02, 2026
Presentation THT 2026 HeartCon: Pioneering VAD Development in China Presenter: Xiaocheng Liu March 02, 2026
Presentation THT 2026 Predicted vs. Observed 3-Year Mortality in the ALT FLOW Early Feasibility Study Cohort Presenter: Javed Butler March 02, 2026
Presentation THT 2026 Disentangling The Central, Peripheral And Hematological Mechanisms Of Benefit Of Sotatercept On Exercise Performance In Pulmonary Arterial Hypertension Presenter: Yogesh Reddy March 02, 2026
Presentation THT 2026 Effect of Cardiac Contractility Modulation (CCM) Therapy on Reverse Remodeling in Heart Failure Patients with Left Ventricular Ejection Fraction 25-45% Presenter: Rami Kahwash March 02, 2026
Presentation THT 2026 Relationship Between Remote, Ambulatory Pulmonary Artery Pressures, and the Risk of Heart Failure Hospitalizations in Patients With Chronic Heart Failure Presenter: Michael R. Zile March 02, 2026
Presentation THT 2026 Prospective Validation of the STOPSHOCK Score for Early Cardiogenic Shock Prediction in Acute Coronary Syndrome: A Real-World Perspective Presenter: Allan Böhm March 02, 2026
Presentation THT 2026 Initial Six-Month Outcomes With Baroreflex Activation Therapy From the REBALANCE Registry Presenter: Dmitry Yaranov March 02, 2026
Presentation THT 2026 Autologous Cell Therapy May Curb Pathological Ventricular Remodeling in Chronic Ischemic HFrEF Patients Selected for Favorable Cell Characteristics - Late Breaking Echocardiography Results from the CardiAMP HF trial Presenter: Amish Raval March 02, 2026
Presentation THT 2026 Thirty-Day Mortality With Impella Versus Intra-Aortic Balloon Pump in STEMI-Related Cardiogenic Shock: A Systematic Review Presenter: Hriday Shah March 02, 2026
Presentation THT 2026 Optimization of Guideline-Directed Medical Therapy and Volume Stability Using an AI-Enabled Virtual Heart Failure Care Platform Across Community Cardiology Practices Presenter: Trejeeve Martyn March 02, 2026